Abbott Afinion HbA1c Dx Assay

Abbott announced that its Afinion HbA1c Dx assay is available for use on its Afinion 2 and Afinion AS100 analyzers. The Afinion HbA1c Dx assay is the first rapid point-of-care test cleared by the US Food and Drug Administration (FDA) to aid healthcare professionals in the diagnosis of diabetes and the assessment of patients' risk of developing the condition, Abbott said.

The test delivers accurate and precise HbA1c results in three minutes, enabling clinicians to diagnose patients and help them formulate individualized care plans during a single doctor's office visit, the firm said.